Nattokinase enhances the sensitivity of cancer cells to oxaliplatin through mitochondrial pathway and induction of apoptosis

Nattokinase enhances the sensitivity of cancer cells to oxaliplatin through mitochondrial pathway and induction of apoptosis

Combination therapy consisting of anticancer drugs has been used to decrease the adverse effects and increase the effectiveness of the drugs. The present study aimed to examine the synergistic effect and potential mechanisms of oxaliplatin and nattokinase (NK) combined treatment for BGC-823, HepG-2,...

Full description

Bibliographic Details
Main Authors: Yong-Po Zhang, Yue-Wei Tian, Jiang Geng, Xin-Hui Zhou, Meng-Ze Li, Guang-Huan Liu, Chun-Yan Gao, Ai-Qin Yue, Jin-Zhong Zhao, Wei-Jun Du
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Arabian Journal of Chemistry
Subjects:
Oxaliplatin
Nattokinase
Combination
Anticancer
Mitochondrial pathway
Online Access:http://www.sciencedirect.com/science/article/pii/S1878535223009401

Internet

http://www.sciencedirect.com/science/article/pii/S1878535223009401

Similar Items